A recent analysis of the same study population showed that the majority of Caucasian patients with anti-RHA were at an early stage of SLE; 5 out of 8 anti-RHA patients were within one year of diagnosis [7]. This evidence concerns the gene DHX9 and systemic lupus erythematosus.